CD Formulation's liposome drug delivery platform offers a comprehensive, one-stop service for developing drug delivery systems. Our platform efficiently synthesizes lipids, prepares liposomes, optimizes and develops processes, researches quality, evaluates safety, and more.
Items | Descriptions |
---|---|
Solvent Injection Method | This straightforward technique for creating liposomes involves dissolving lipids in an organic solvent and injecting the drug into this mixture at a regulated pace to form liposomes. |
Thin Film Dispersion Method | This method involves dissolving drugs and lipids in an organic solvent, then using a rotary evaporator to remove the solvent under reduced pressure, forming a thin lipid layer. Adding an aqueous medium hydrates and separates the film to produce drug-laden liposomes. |
Reverse Phase Evaporation Method | This approach mixes a lipid-containing organic solution with a drug-containing aqueous solution via sonication to create W/O emulsions. Liposomes result from evaporating the mixture under reduced pressure, suitable for water-soluble drugs and large molecules. |
Extrusion Method | Liposomes undergo external pressure, squeezing through a filter with pore sizes smaller than the liposomes. This shearing force deforms and ruptures the liposomes, which then quickly reform into smaller units. |
Microfluidic Technology | This method offers fast and efficient liposome production by controlling microfluid flow and mixing within channels, resulting in precise and uniform liposomes. |
We employ advanced technologies to protect the integrity and activity of nucleic acids during delivery, preventing degradation in both in vivo and ex vivo environments. Our approach ensures that nucleic acid components maintain effective biological activity before reaching target cells.
To enhance nucleic acid drug delivery efficiency, we design various liposome structures to optimize the delivery process. By adjusting the particle size, surface charge, and encapsulation rate of liposomes, we can significantly improve the cellular uptake of nucleic acids.
CD Formulation offers not only standardized products but also personalized customization options designed for different nucleic acid drugs. We optimize lipid and nucleic acid combinations according to specific therapeutic needs to achieve more precise drug action.
We provide a complete quality control and safety evaluation system for liposomal nucleic acid drugs. This includes thorough testing from nucleic acid purity to liposome characteristics, ensuring each drug meets the highest standards.
TEM enables visualization of liposomes, emphasizing their morphology and structure. While cryo-TEM is the best choice, negative staining offers a simpler, faster method. Notably, liposome shape may deform during staining and drying.
By labeling the lipid bilayer with fluorescent markers, the structure of liposomes can be studied in confocal images, allowing non-destructive 3D image reconstruction. It is a good technique for evaluating internal structures of large multilayer vesicles; however, it cannot resolve structures below 200nm, like small unilamellar vesicles.
This equipment offers high-throughput analytical capability, aiding in calculating the encapsulation efficiency (EE) of liposomes. Even without any purification of liposomes (e.g., SEC, dialysis), EE can still be assessed using HPLC. The technology also monitors storage stability related to leakage or the impact of various disruptive conditions on encapsulated materials.
Technology: Liposome-assisted drug delivery platform for encapsulating drugs
Journal: Frontiers in pharmacology
IF: 4.4
Published: 2024
Results:
Liposomes enhance the stabilization of therapeutic compounds, aiding cellular and tissue uptake while improving biodistribution at target sites in vivo. They enable efficient delivery of encapsulated compounds and reduce systemic toxicity. Their flexible physicochemical and biophysical properties make them an appealing delivery system for various needs. This review will address advancements and ongoing biological challenges in liposome-assisted drug delivery.
Fig.1 Schematic representation of the different types of liposomal drug delivery systems. (Sercombe L, et al., 2015)
CD Formulation is committed to supporting your projects by leveraging our expert knowledge and state-of-the-art equipment, ensuring a high level of after-sales service. With our liposome drug delivery system platform, we provide optimized solutions tailored to your research needs. Don't hesitate to reach out to us, we're eager to become your trusted partner.
References